Open AccessDual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib
Author(s) -
Youcai Zhu,
Bing Wan,
Lixin Wu,
Xingliang Li,
Wenxian Wang,
Chunwei Xu,
Wu Zhuang,
Jianguo Wei,
Kaiqi Du
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.06.23
Subject(s) - crizotinib , anaplastic lymphoma kinase , kras , cancer research , chromosomal translocation , lung cancer , adenocarcinoma , fusion gene , alk inhibitor , epidermal growth factor receptor , biology , mutation , tyrosine kinase , tyrosine kinase inhibitor , medicine , cancer , oncology , gene , genetics , receptor , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom